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352a Monday, February 27, 2012ratio of myosin heavy chain (MyHC) isoforms, a- and b-MyHC, expressed in
the ventricles. Normal human ventricles express ~10% of the fast a-MyHC
on a background of the slower b-MyHC, while in failing hearts a-MyHC is re-
duced to virtually undetectable levels with complete replacement by b-MyHC.
Data from permeabilized myocardial preparations suggests that this isoform
switch may be partly responsible for reduced myocardial twitch force and pres-
sure development by failing ventricles since b-MyHC is a slower motor protein,
yet most experiments have used non-human myosins and experimental condi-
tions in which preparations were steadily activated, thus little is known about
the response of human myosins to a time-varying Ca2þ transient. To address
these limitations, we recently developed a human 3D engineered cardiac tissue
(hECT) system in which we can express recombinant human muscle myosin
motors. Using commercially available cloning and adenoviral expression sys-
tems, a- or b-MyHC isoform expressing adenoviral particles were used to trans-
duce human cardiomyocytes produced from human iPS cells and construct
hECTs. Preparations displayed well-defined cellular structure with elongated
morphology aligned in the direction of preparation shortening during electrical
pacing, while histological analysis of hECT revealed appropriate protein ex-
pression and localization within the sarcomere. In response to a Ca2þ transient,
the time-course of twitch force development was accelerated in hECT express-
ing a-MyHC compared to b-MyHC, while peak twitch force was greater in
hECT expressing a-MyHC. These results demonstrate the relative contribution
of myosin isoforms to myocardial twitch kinetics in human engineered cardiac
tissue constructs expressing a stable background of myofibrillar proteins.
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Current laboratory methods used to assess neonatal and adult cardiocyte func-
tion include measurement of gene and protein expression levels, calcium tran-
sients, and contractility. Our goal was to develop simple tools to analyze such
data readily. We created two MATLAB-based toolboxes; the Contraction
Video Processing (CVP) and the Cardiocyte Functional Response Analysis
(CFRA) Toolbox. Videos of contracting cultured cardiocytes are acquired us-
ing a digital camera attached to an inverted phase microscope. Video frames
are analyzed using digital imaging processing techniques along with several
contraction assessment methods available through the CVP toolbox. The
CVP offers direct correlation, pixel intensity tracking and Polar Fourier trans-
form methods for the analysis of neonatal cardiocyte contraction. Analysis of
adult cardiocytes includes those implemented on neonatal cardiocytes in addi-
tion to area boundary tracking, Fourier descriptor analysis, and cell length
tracking methods. The resulting contraction records are processed using the
CFRA toolbox to provide quantitative analyses of cardiocyte contractility
and calcium transient responses. Transient data are obtained by measuring
the calcium fluxes using the fluorescent dye Fluo-3, and a Photon Technology
fluorometer system running Felix software. Data analysis routines have been
created and tailored exclusively to the characteristics and needs of cellular car-
diovascular research investigators. The analytical methods created are used to
find the onset of contraction, perform signal averaging, and acquire statistical
information of functional data. CFRA toolbox contractility processing yields
onset time, time-to-peak, duration, and fast and slow recovery times. CFRA
toolbox calcium transient signal processing yields onset time, signal intensity,
and fast and slow exponential recovery rates associated with SERCA and NCX
channels respectively. The toolboxes allow examination of beat-to-beat con-
tractility and calcium transient variations within the same cardiocyte as well
as from cell population to population. Supported by NIH/NIGMS SDSU
MARC Program 5T34GM008303-22
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Cardiac hypertrophy is associated with Diastolic Heart Failure (DHF), a syn-
drome in which systolic function is preserved, but cardiac filling dynamics
are depressed. The molecular mechanisms underlying DHF and the potential
role of altered cross-bridge cycling in this syndrome are poorly understood.
Accordingly, we induced chronic pressure overload by surgically banding the
thoracic ascending aorta in female Dunkin Hartley Guinea pigs weighing
400g, for 12-16 weeks. Guinea pigs were chosen to avoid the confounding ef-
fects of myosin isoform switch that occurs in other small rodent models. Left
ventricular (LV) samples were frozen in liquid N2. Aortic banding resulted
in (þ31%) LV hypertrophy (LV/BW ratio) and reduced diastolic cardiac
function, but normal systolic function. Single myofibrils were prepared by me-chanical dissociation and subsequently attached between two glass micro-
needles that were positioned on the stage of an inverted phase-contrast micro-
scope. While the maximum calcium saturated force development was de-
pressed (18%), the time required for force relaxation was increased (þ8%)
in parallel to a significant decrease in the rate of relaxation (25%) in DHF
myofibrils; Myosin Heavy Chain (MHC) isoform distribution was unaltered.
We conclude that slower cross-bridge relaxation kinetics contribute to diastolic
dysfunction in cardiac hypertrophy.
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Heart failure is a progressive condition in which the ventricles can no longer
pump enough blood to meet the body’s basal demands. Our laboratory is inves-
tigating whether the transmural variation in cellular contractile properties that
occurs in normal hearts (and which is thought to be important for ventricular
function) is altered in heart failure. We procured through wall samples of fail-
ing left ventricle from patients receiving transplants at the University of
Kentucky and non-failing samples from brain dead organ donors. The tissue
was divided into epicardial, midmyocardial and endocardial layers and frozen
in liquid nitrogen within 30 minutes. Multicellular chemically permeabilized
preparations were subsequently obtained from these samples by mechanical ho-
mogenization and triton treatment. The samples were attached between a force
transducer and a motor and subjected to two mechanical protocols: 1) a stretch-
restretch protocol in solutions with different activating Ca2þ concentrations
and 2) a force-velocity protocol in which maximally-activated preparations
were allowed to shorten against pre-set loads. Parameters including steady-
state force, short-range stiffness, short-range force and maximum power output
were measured using these two protocols. The results suggested a 30% decrease
in maximum power output (p-value = 0.01) and steady-state force (p-
value=0.005) in heart failure patients (n=8, total of 72 preparations) as
compared to non-failing (n=4, total of 36 preparations). Short-range stiffness
(p-value=0.003) and short-range force (p-value=0.002) also significantly de-
creased in heart failure vs. non-failing. Transmurally there was a significant dif-
ference in maximum power output between the regions (p-value=0.02). The
data suggests that mechanically the mid myocardium maybe affected the
most in heart failure. Further studies need to be done to understand the protein
modifications that may be responsible for these variations.
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Pulmonary artery hypertension (PAH) can cause right ventricular (RV) con-
tractile dysfunction and failure by mechanisms that are not fully understood.
PAH and RV failure were induced in male Wistar rats (200g) 3-4 weeks after
a single injection of 60 mg/kg monocrotaline (MCT). Single RV myocytes
were isolated from extracted hearts and fast Fourier transform of their video im-
age was used to compare resting sarcomere lengths (SL) of myocytes from
MCT and saline injected control animals (CON) during superfusion with
a physiological saline solution.
There was no difference in resting intracellular Ca2þ levels in cells loaded
with the Ca2þ-indicator Fura-4 (MCT 0.31 5 0.02 ratio units n= 10 cells;
CON, 0.305 0.01 ratio units n= 11 cells, P > 0.05, unpaired t-test). However,
resting SL was significantly shorter in MCT myocytes (1.785 0.01 mm) than
CON (1.905 0.01 mm) P < 0.001. When Ca2þ-dependant cross-bridges were
inhibited by exposure to the Ca2þ buffer BAPTA-AM (100 mM for 10 min) SL
increased in both groups by similar amounts (MCT 0.015 0.003 mm vs CON
0.03 5 0.01 mm, P > 0.05). Inhibition of Ca2þ-independent cross-bridges by
exposure to BAPTA plus the actin-myosin inhibitor BDM (40 mM for
5 min) further increased SL, this effect was significantly greater in MCT
Monday, February 27, 2012 353amyocytes (MCT 0.085 0.01 mm vs CON 0.045 0.01 mm, P < 0.001). MCT
n = 25 cells; CON n = 18 cells, 2 way RM ANOVA.
We conclude that the shorter resting SL in MCT myocytes is due to the forma-
tion of Ca2þ-independent cross-bridges, we speculate that these are formed in
response to disturbances in cellular metabolism, by mechanisms currently un-
der investigation.
Supported by the BHF and MRC
1791-Pos Board B561
A Single Strain-Based Growth Law Predicts Concentric and Eccentric
Cardiac Growth during Pressure and Volume Overload
Roy Kerckhoffs, Jeffrey Omens, Andrew McCulloch.
University of California, San Diego, La Jolla, CA, USA.
Adult cardiac muscle adapts to changes in the environment by growth and
remodeling via a variety of mechanisms. Hypertrophy develops when the
heart is subjected to chronic mechanical overload. In ventricular pressure
overload (due to aortic stenosis) the heart typically reacts by concentric hy-
pertrophic growth, characterized by wall thickening due to myocyte thicken-
ing when sarcomeres are added in parallel. In ventricular volume overload,
an increase in filling pressure (due to mitral regurgitation) leads to eccentric
hypertrophy as myocytes grow axially by adding sarcomeres in series lead-
ing to ventricular cavity enlargement that is typically accompanied by some
wall thickening. The specific biomechanical stimuli that stimulate different
modes of hypertrophy are still poorly understood. Recently, we proposed
that cardiac myocytes grow longitudinally to maintain a preferred sarcomere
length in response to increased fiber strain and axially to maintain interfila-
ment lattice spacing in response to increased crossfiber strain. Here, we test
whether this growth law is able to predict concentric and eccentric hypertro-
phy in response to aortic stenosis and mitral valve regurgitation, respec-
tively, in a computational model of the adult canine heart coupled to
a closed loop model of circulatory hemodynamics. A finite element model
of the beating canine ventricles coupled to the circulation that was used. Af-
ter inducing valve alterations, the ventricles were allowed to adapt in shape
in response to mechanical stimuli over time. The proposed growth law was
able to reproduce major acute and chronic physiological responses when in-
tegrated with comprehensive models of the pressure- and volume-overloaded
canine heart, coupled to a closed-loop circulation. We conclude that strain-
based biomechanical stimuli consistent with in-vitro studies of myocyte
stretch responses can drive cardiac growth, including wall thickening during
pressure overload.
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Background: Hypertrophic cardiomyopathy (HCM) is frequently caused by
mutations in genes encoding sarcomeric proteins. Previously, we observed a re-
duced maximal force generating capacity (Fmax) of cardiomyocytes from
HCM patients with mutations in myosin-binding protein-C (MYBPC3). In
this study we investigated the contribution of myofibril density (MyoD) and
cross-sectional area (CSA) to the reduction in Fmax.
Methods: We measured Fmax and CSA of single permeabilized ventricular
cardiomyocytes of 27 HCM patients with mutations in MYBPC3, myosin
heavy chain: MYH7, troponin T: TNNT2 and troponin I: TNNI3 and 10
non-failing donor hearts. MyoD was calculated as the sum of myofibril area re-
lated to cell area assessed by electron microscopy.
Results: Average Fmax was significantly lower in HCM groups compared to
donor (Figure A). Figure B shows that MyoD of HCM hearts was reduced com-
pared to donors. CSA of HCM hearts (529548mm2) was significantly higher
compared to donors (342512mm2). Linear regression analysis revealed a
significant negative linear relationship between CSA and Fmax (R2= 0.50,
b=-0.023, p=0.014).Conclusion: Cardio-
myocyte hypertro-
phy and reduced
myofibrillar density
underlie depressed
Fmax in HCM with
mutations in thick
and thin sarcomeric
proteins.
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SPontaneous Oscillatory Contraction (SPOC) is a physiological state induced
in striated muscle fibres under conditions of partial activation. SPOC is charac-
terised by repetitive auto-oscillations between cycles of rapid lengthening and
slow shortening that correlate with diastole and systole respectively. We acti-
vate cardiomyocytes using ADP-induced SPOC and Ca2þ induced SPOC.
Ca-SPOC correlates well with heart rate observed in a number of animal
models.
The current study quantifies contractile performance of cardiomyocytes iso-
lated from human dilated and hypertrophic cardiomyopathies (some with
known mutations) and compares them with age-matched non-failing donors.
Measured parameters of contractile performance include the velocity, period
and amplitude of contraction, relaxation and SPOC-wave. We compare
changes in contractile performance between (1) failing and non-failing hearts,
(2) hearts from a wide range of donor ages, and (3) differences between ADP-
and Ca-SPOC. These observations are then related to patient clinical data (e.g.
ejection fraction).
Interestingly, human heart samples flash frozen (200C) within minutes of the
loss of coronary blood flow can be re-activated even after up to 20 years of stor-
age. Cardiac muscle fibres from the left atria and left ventricles, interventricular
septa and papillary muscles were specially defrosted prior to microdissection.
Length changes were measured using a Leica SP5 multi-photon microscope
and then averaged at high spatial and temporal resolution.
Preliminary data identify measureable changes in contractile performance be-
tween non-failing and failing hearts. Samples of hypertrophic cardiomyopathy
exhibit decreased rates of relaxation consistent with their clinical diagnosis.
These observations reveal SPOC to yield a range of functional parameters
that can be used to evaluate the functional state of human heart muscle fibres.
Thus, SPOC may prove to be a valuable measurement that can objectively as-
sess the state of human heart failure.
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It is generally believed that the rhythmof heartbeat is controlled by electric stim-
ulations produced by pacemaker cells. However, sarcomeres in cardiac myofi-
brils exhibit spontaneous rhythmic oscillations of sarcomere length (SL) and
force under partial activation conditions (i.e., SPOC). SPOC occurs either at
pCa~6.0 (Ca-SPOC ) or at the coexistence of MgADP and Pi in the absence of
Ca2þ (ADP-SPOC) (Ishiwata et al., 2011). We have reported that the SPOC pe-
riod correlates strongly with the resting heart rate in various animal species
(Sasaki et al., 2006). In the present study, to test whether SPOC plays a key
role in the regulation of heartbeat, we performed analyses on thewaveformprop-
erties of SPOC by using rat neonatal cardiomyocytes expressing AcGFP in the
Z-lines. First, we found that SPOC occurs in the neonatal myocytes treated
with ionomycin at pCa ~6.0 (pCa adjusted by Ca/EGTA), viz., in the presence
